AQST - Aquestive Therapeutics GAAP EPS of -$1.85 misses by $0.36 revenue of $50.83M beats by $1.73M March, 08 2022 05:07 PM Aquestive Therapeutics Inc. Aquestive Therapeutics press release (NASDAQ:AQST): FY GAAP EPS of -$1.85 misses by $0.36. Revenue of $50.83M (+10.9% Y/Y) beats by $1.73M. For further details see: Aquestive Therapeutics GAAP EPS of -$1.85 misses by $0.36, revenue of $50.83M beats by $1.73M